MassBio’s latest Biopharma Funding Report shows Massachusetts biopharma companies raised record-breaking $5.8 billion in VC Funding in 2020.
MassBio today released its 2020 Massachusetts Biopharma Funding Report, which shows that the Massachusetts biopharma industry experienced its best funding year on record. In 2020, venture capital investment in Massachusetts biopharma companies reached $5.8 billion, surpassing 2018’s previous recorded high of $4.8 billion.
In addition, 21 Massachusetts biotech companies went public in 2020, a 110% increase from 2019, totaling $3.9 billion raised. These Massachusetts companies accounted for 32% of all United States-based biotech IPOs by volume. Additionally, two Massachusetts biotechs went public through a special purpose acquisition company (SPAC) merger in 2020, representing 50% of all United States-based biotech SPAC mergers in 2020.
The report also found that Cambridge, Massachusetts remains a driving force within the life sciences industry. Cambridge-based biopharma companies received 55% of all biotech VC investment in Massachusetts and raised 63% of all IPO money.
To download the full report, click here.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.